This new meta-analysis looked to better solidify connections between atopic dermatitis and environmental irritants, such as climate change and pollution.
With new data showing a stronger potential connection between atopic dermatitis (AD) and increased levels of environmental pollutants, the population burden of this chronic inflammatory skin condition that is also considered an immune-mediated disease remains significant—with potential to continue to grow.
If measures to mitigate how pollution and climate change do not improve, neither may patient outcomes, according to a new meta-analysis published in JAMA Dermatology.1 Using MEDLINE, EMBASE, and Cochrane databases, a team of investigators searched for research on correlations between AD outcomes and environmental factors—ambient air pollution, weather, and climate—from inception to June 28, 2024. These cohort, case-control, cross-sectional observations studies were of adult patients 18 years and older; ultimately, 42 studies from 14 countries and 1985 to 2024 were included, with certainty of evidence assessed using Grading of Recommendations Assessment, Development, and Evaluation.
After reviewing their findings, the authors saw an uptick in AD outpatient clinical visits per 4 ambient environmental pollutants, using 10-μg/m3 increases as measures:
The population burden of atopic dermatitis, a chronic inflammatory skin condition that is also considered an immune-mediated disease remains significant; if measures to mitigate how pollution and climate change do not improve, neither may patient outcomes. | Image Credit: Maggie Shaw-sora.chatgpt.com
“To our knowledge, research on the association of environmental factors and atopic dermatitis has not been comprehensively synthesized alongside an assessment of the certainty of evidence,” the authors wrote. They also highlighted that these associations remain uncertain, with some studies reporting links between AD and particulate matter and harmful gas increases but others reporting no associations or that cold weather worsens the AD burden.2-6
The authors also saw a rise in emergency department (ED) visits. For every 10-μg/m3 increase in particulate matter 10 μm in diameter or smaller, there was a 1% increase in ED or clinical visits (RR, 1.008; 95% CI, 1.003-1.012; high-certainty evidence), and for every 10-μg/m3 increase in particulate matter 2.5 μm in diameter or smaller, there was “probably an increase” in ED or clinical visits (RR, 1.013; 95% CI, 0.999-1.027; moderate-certainty evidence).
Looking at adulthood specifically, there is likely no association between exposure to nitric oxide or nitrogen dioxide and AD in adulthood; no studies included in this meta-analysis showed increases in medical visits at elevated levels.
Also, accounting for temperature, 10 studies demonstrated correlations between higher temperatures in hot climates or seasons and more AD-related ED or clinical visits. This association was more likely to be seen in female individuals compared with male individuals, but for outpatient visits. Six studies also reported links between lower temperatures in cold climates and seasons and more daily AD-related ED or clinical visits.
Precipitation and sunlight were examined as well, and although the evidence was deemed low certainty, the authors saw potential connections each between high amounts of precipitation and humidity and greater AD severity.
Probable associations were seen, too, between the following and greater AD prevalence: environmental tobacco smoke and traffic-related air pollution, secondhand smoke, and traffic and industrial plants exposure.
Overall, the associations they saw indicated harmful correlations between population-level AD activity and various ambient air pollutants. These findings are strong, the authors explained, because their review synthesized evidence on broad factors and the results were generally consistent with previous reviews, including recent studies.
“These findings have direct public health implications, adding to the impetus to decrease pollution and mitigate climate change worldwide,” they concluded.
References
Advancing Women's Health: CVS Health Leader on Access, Technology, and Breaking Stigmas
December 5th 2024On this episode of Managed Care Cast, we speak with CVS Health's vice president and chief medical officer for women's health and genomics about advancements and challenges in women's health, focusing on care access, technology, and maternal outcomes.
Listen
Moving Evidence From Research to Practice: Q&A With Ken Cohen, MD
June 23rd 2025In 2025, each issue of Population Health, Equity & Outcomes will feature a profile of a health system leader transforming care in their area of expertise. This issue spotlights a conversation with Ken Cohen, MD, executive director of translational research at Optum Health.
Read More
Healing Wounds Through Peer Support
September 16th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In this third episode, we speak with Kim MacDonald-Wilson, ScD, CPRP, and Tracy Carney, CPS, CPRP.
Listen
Pediatric Atopic Dermatitis Linked to Allergy Development
June 13th 2025Outcomes were evaluated among children born between April 1980 and June 2019 by using data from 12 observational birth cohorts from the Environmental Influences on Child Health Outcomes Children’s Respiratory and Environmental Workgroup.
Read More